Autoregulatory feedback loops terminating the NF-κB response

Trends in Biochemical Sciences

Volumn 34, Issue 3, 2009, Pages 128-135

  Renner, Florian ^a   Schmitz, M Lienhard ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SUMO PROTEIN;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOREGULATION; GENE TARGETING; HUMAN; INNATE IMMUNITY; MOLECULAR CLOCK; NEGATIVE FEEDBACK; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 62849118323     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2008.12.003     Document Type: Review

References (72)

1. Tiana G., et al. Oscillations and temporal signalling in cells. Phys. Biol. 4 (2007) R1-R17
2. Medzhitov R. Origin and physiological roles of inflammation. Nature 454 (2008) 428-435
3. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6 (2005) 1191-1197
4. Winsauer G., and de Martin R. Resolution of inflammation: intracellular feedback loops in the endothelium. Thromb. Haemost. 97 (2007) 364-369
5. Cheong R., et al. Transient IκB kinase activity mediates temporal NF-κB dynamics in response to a wide range of tumor necrosis factor-α doses. J. Biol. Chem. 281 (2006) 2945-2950
6. Cheong R., and Levchenko A. Wires in the soup: quantitative models of cell signaling. Trends Cell Biol. 18 (2008) 112-118
7. Natoli G., and Chiocca S. Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation. Sci. Signal. 1 (2008) pe1
8. Divanovic S., et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6 (2005) 571-578
9. Poltorak A., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
10. Kumar S., et al. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem. Biophys. Res. Commun. 235 (1997) 474-478
11. Kobayashi K., et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110 (2002) 191-202
12. Balaci L., et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 80 (2007) 1103-1114
13. Rao N., et al. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol. Cell. Biol. 25 (2005) 6521-6532
14. Burns K., et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197 (2003) 263-268
15. Janssens S., et al. MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression. FEBS Lett. 548 (2003) 103-107
16. Evans P.C., et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378 (2004) 727-734
17. Lin S.C., et al. Molecular basis for the unique deubiquitinating activity of the NF-κB inhibitor A20. J. Mol. Biol. 376 (2008) 526-540
18. Wertz I.E., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430 (2004) 694-699
19. Shembade N., et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9 (2008) 254-262
20. Iha H., et al. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-κB activation. EMBO J. 27 (2008) 629-641
21. Wullaert A., et al. LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-κB activation. J. Biol. Chem. 282 (2007) 81-90
22. Wagner S., et al. Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins. Oncogene 27 (2008) 3739-3745
23. Enesa K., et al. NF-κB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 283 (2008) 7036-7045
24. Courtois G. Tumor suppressor CYLD: negative regulation of NF-κB signaling and more. Cell. Mol. Life Sci. 65 (2008) 1123-1132
25. Massoumi R., et al. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling. Cell 125 (2006) 665-677
26. Reiley W., et al. Regulation of the deubiquitinating enzyme CYLD by IκB kinase γ-dependent phosphorylation. Mol. Cell. Biol. 25 (2005) 3886-3895
27. Zhang J., et al. Impaired regulation of NF-κB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J. Clin. Invest. 116 (2006) 3042-3049
28. Scharschmidt E., et al. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-κB signaling. Mol. Cell. Biol. 24 (2004) 3860-3873
29. Lobry C., et al. Negative feedback loop in T cell activation through IκB kinase-induced phosphorylation and degradation of Bcl10. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 908-913
30. Wegener E., et al. Essential role for IκB kinase β in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol. Cell 23 (2006) 13-23
31. Shi M., et al. TRIM30 α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9 (2008) 369-377
32. Tanaka T., et al. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 8 (2007) 584-591
33. Maine G.N., et al. COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase. EMBO J. 26 (2007) 436-447
34. Arlt A., et al. IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis. Biochim. Biophys. Acta 1783 (2008) 941-952
35. Sosic D., et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-κB activity. Cell 112 (2003) 169-180
36. Totzke G., et al. A novel member of the IκB family, human IκB-ζ, inhibits transactivation of p65 and its DNA binding. J. Biol. Chem. 281 (2006) 12645-12654
37. Liu B., et al. Proinflammatory stimuli induce IKKα-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell 129 (2007) 903-914
38. Lawrence T., et al. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434 (2005) 1138-1143
39. de Martin R., et al. Cytokine-inducible expression in endothelial cells of an IκB α-like gene is regulated by NF κB. EMBO J. 12 (1993) 2773-2779
40. Sun S.C., et al. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
41. Brown K., et al. Mutual regulation of the transcriptional activator NF-κB and its inhibitor. IκB-α. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2532-2536
42. Scott M.L., et al. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7 (1993) 1266-1276
43. Budde L.M., et al. Regulation of IκBβ expression in testis. Mol. Biol. Cell 13 (2002) 4179-4194
44. Kearns J.D., et al. IκBε provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression. J. Cell Biol. 173 (2006) 659-664
45. Zabel U., and Baeuerle P.A. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61 (1990) 255-265
46. Klement J.F., et al. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16 (1996) 2341-2349
47. Cheng J.D., et al. Functional redundancy of the nuclear factor κB inhibitors IκBα and IκBβ. J. Exp. Med. 188 (1998) 1055-1062
48. Werner S.L., et al. Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20. Genes Dev. 22 (2008) 2093-2101
49. Yang X.P., et al. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo. J. Hepatol. 43 (2005) 704-710
50. Frobose H., et al. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20 (2006) 1587-1596
51. Rothlin C.V., et al. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131 (2007) 1124-1136
52. Mansell A., et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7 (2006) 148-155
53. Delhase M., et al. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 284 (1999) 309-313
54. Li H.Y., et al. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat. Immunol. 9 (2008) 533-541
55. Taganov K.D., et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12481-12486
56. El Gazzar M., et al. G9a and HP1 couple histone and DNA methylation to TNFα transcription silencing during endotoxin tolerance. J. Biol. Chem. 283 (2008) 32198-32208
57. Foster S.L., et al. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447 (2007) 972-978
58. Fiorini E., et al. Peptide-induced negative selection of thymocytes activates transcription of an NF-κB inhibitor. Mol. Cell 9 (2002) 637-648
59. Wald D., et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4 (2003) 920-927
60. Wu M., et al. SINK is a p65-interacting negative regulator of NF-κB-dependent transcription. J. Biol. Chem. 278 (2003) 27072-27079
61. Kawai T., and Akira S. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13 (2007) 460-469
62. Wietek C., and O'Neill L.A. Diversity and regulation in the NF-κB system. Trends Biochem. Sci. 32 (2007) 311-319
63. Schmitz M.L., et al. NF-κB: a multifaceted transcription factor regulated at several levels. ChemBioChem 5 (2004) 1348-1358
64. Perkins N.D. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8 (2007) 49-62
65. Meylan E., et al. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
66. Covert M.W., et al. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309 (2005) 1854-1857
67. Hayden M.S., and Ghosh S. Shared principles in NF-κB signaling. Cell 132 (2008) 344-362
68. Hacker H., and Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006 (2006) re13
69. Liu Y.C., et al. Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 5 (2005) 941-952
70. Wullaert A., et al. Ubiquitin: tool and target for intracellular NF-κB inhibitors. Trends Immunol. 27 (2006) 533-540
71. Sun S.C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8 (2008) 501-511
72. Meulmeester E., and Melchior F. Cell biology: SUMO. Nature 452 (2008) 709-711